T. Rowe Price Associates’s Privia Health PRVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Buy |
92,321
+13,929
| +18% | +$320K | ﹤0.01% | 1609 |
|
|
2025
Q1 | $1.76M | Buy |
78,392
+4,976
| +7% | +$112K | ﹤0.01% | 1663 |
|
|
2024
Q4 | $1.44M | Buy |
73,416
+9,880
| +16% | +$193K | ﹤0.01% | 1791 |
|
|
2024
Q3 | $1.16M | Buy |
63,536
+1,429
| +2% | +$26K | ﹤0.01% | 1911 |
|
|
2024
Q2 | $1.08M | Buy |
62,107
+13,771
| +28% | +$239K | ﹤0.01% | 1870 |
|
|
2024
Q1 | $947K | Sell |
48,336
-672,627
| -93% | -$13.2M | ﹤0.01% | 1937 |
|
|
2023
Q4 | $16.6M | Sell |
720,963
-214,054
| -23% | -$4.93M | ﹤0.01% | 991 |
|
|
2023
Q3 | $21.5M | Sell |
935,017
-21,164
| -2% | -$487K | ﹤0.01% | 901 |
|
|
2023
Q2 | $25M | Buy |
956,181
+868,709
| +993% | +$22.7M | ﹤0.01% | 876 |
|
|
2023
Q1 | $2.42M | Buy |
87,472
+10,957
| +14% | +$303K | ﹤0.01% | 1405 |
|
|
2022
Q4 | $1.74M | Buy |
76,515
+2,077
| +3% | +$47.2K | ﹤0.01% | 1524 |
|
|
2022
Q3 | $2.54M | Sell |
74,438
-2,705,766
| -97% | -$92.2M | ﹤0.01% | 1368 |
|
|
2022
Q2 | $81M | Buy |
2,780,204
+1,162,270
| +72% | +$33.8M | 0.01% | 724 |
|
|
2022
Q1 | $43.2M | Buy |
1,617,934
+499,816
| +45% | +$13.4M | ﹤0.01% | 1014 |
|
|
2021
Q4 | $28.9M | Buy |
1,118,118
+469,625
| +72% | +$12.1M | ﹤0.01% | 1191 |
|
|
2021
Q3 | $15.3M | Sell |
648,493
-2,158,846
| -77% | -$50.9M | ﹤0.01% | 1356 |
|
|
2021
Q2 | $125M | Buy |
+2,807,339
| New | +$125M | 0.01% | 707 |
|